Interestingly, monoclonal antibodies targeting periostin have emerged with promising results in preclinical models of breast and ovarian cancer88; nevertheless, their role in MM pathogenesis remains to be investigated. The gene discussed is POSTN; the disease is Miyoshi myopathy.